CTLA4 and gastric adenocarcinoma: Previous studies in stomach adenocarcinoma have similarly shown that dense ECM deposition can restrict T cell infiltration and interfere with the effectiveness of checkpoint blockade therapies, particularly those targeting PD1 and CTLA4 [95].